Alexi A. Wright

15.5k total citations · 7 hit papers
163 papers, 10.2k citations indexed

About

Alexi A. Wright is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alexi A. Wright has authored 163 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 59 papers in Public Health, Environmental and Occupational Health and 40 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alexi A. Wright's work include Palliative Care and End-of-Life Issues (53 papers), Childhood Cancer Survivors' Quality of Life (33 papers) and Ovarian cancer diagnosis and treatment (33 papers). Alexi A. Wright is often cited by papers focused on Palliative Care and End-of-Life Issues (53 papers), Childhood Cancer Survivors' Quality of Life (33 papers) and Ovarian cancer diagnosis and treatment (33 papers). Alexi A. Wright collaborates with scholars based in United States, Canada and Belgium. Alexi A. Wright's co-authors include Holly G. Prigerson, Susan D. Block, Nancy L. Keating, Tracy A. Balboni, Jane C. Weeks, Ursula A. Matulonis, Jennifer W. Mack, Matthew Nilsson, Craig C. Earle and Ingrid T. Katz and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Alexi A. Wright

155 papers receiving 9.9k citations

Hit Papers

Associations Between End-of-Life Discussions, Patient Men... 2008 2026 2014 2020 2008 2009 2010 2010 2016 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
    2008 2.0k citations Alexi A. Wright profile →
  2. Health Care Costs in the Last Week of Life
    2009 701 citations Alexi A. Wright, Susan D. Block et al. profile →
  3. End-of-Life Discussions, Goal Attainment, and Distress at the End of Life: Predictors and Outcomes of Receipt of Care Consistent With Preferences
    2010 632 citations Jennifer W. Mack, Jane C. Weeks et al. Journal of Clinical Oncology profile →
  4. Place of Death: Correlations With Quality of Life of Patients With Cancer and Predictors of Bereaved Caregivers' Mental Health
    2010 580 citations Alexi A. Wright, Nancy L. Keating et al. Journal of Clinical Oncology profile →
  5. Family Perspectives on Aggressive Cancer Care Near the End of Life
    2016 328 citations Alexi A. Wright, Nancy L. Keating et al. profile →
  6. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
    2016 295 citations Alexi A. Wright, Kari Bohlke et al. Journal of Clinical Oncology profile →
  7. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
    2016 274 citations Alexi A. Wright, Kari Bohlke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexi A. Wright United States 45 6.3k 2.7k 2.2k 2.0k 1.9k 163 10.2k
Frede Olesen Denmark 52 2.1k 0.3× 778 0.3× 2.2k 1.0× 1.1k 0.6× 3.6k 1.9× 227 10.2k
Karen Eden United States 34 3.1k 0.5× 1.5k 0.5× 1.0k 0.5× 588 0.3× 5.2k 2.7× 85 9.3k
Sam H. Ahmedzai United Kingdom 40 4.0k 0.6× 3.4k 1.3× 9.1k 4.2× 900 0.4× 2.0k 1.0× 150 18.0k
Margaret Holmes‐Rovner United States 38 3.5k 0.6× 947 0.4× 1.4k 0.7× 567 0.3× 7.3k 3.8× 106 11.3k
Hilary A. Llewellyn‐Thomas Canada 38 3.5k 0.6× 1.1k 0.4× 1.3k 0.6× 599 0.3× 6.4k 3.4× 81 10.3k
Karen Basen‐Engquist United States 49 1.3k 0.2× 1.2k 0.5× 3.3k 1.5× 834 0.4× 2.6k 1.3× 272 8.5k
Thomas F. Hack Canada 47 5.0k 0.8× 1.1k 0.4× 2.1k 1.0× 3.1k 1.5× 3.5k 1.8× 123 9.7k
Margaret I. Fitch Canada 52 2.8k 0.4× 1.9k 0.7× 4.7k 2.2× 610 0.3× 2.5k 1.3× 368 9.9k
Marcia Grant United States 60 3.6k 0.6× 3.0k 1.1× 4.7k 2.1× 872 0.4× 1.7k 0.9× 278 10.5k
Eva Grunfeld Canada 44 3.2k 0.5× 1.6k 0.6× 4.7k 2.1× 481 0.2× 2.2k 1.2× 203 9.1k

Countries citing papers authored by Alexi A. Wright

Since Specialization
Citations

This map shows the geographic impact of Alexi A. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexi A. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexi A. Wright more than expected).

Fields of papers citing papers by Alexi A. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexi A. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexi A. Wright. The network helps show where Alexi A. Wright may publish in the future.

Co-authorship network of co-authors of Alexi A. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Alexi A. Wright. A scholar is included among the top collaborators of Alexi A. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexi A. Wright. Alexi A. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manz, Christopher R., et al.. (2025). Cancer Screening, Diagnosis, and Treatment for Vulnerable Patients Incarcerated in US Prisons. JCO Oncology Practice. OP2500361–OP2500361. 1 indexed citations
2.
Cham, Stephanie, Niya Xiong, Nabihah Tayob, et al.. (2025). Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma. Gynecologic Oncology Reports. 60. 101796–101796. 1 indexed citations
3.
Konstantinopoulos, Panagiotis A., Elizabeth K. Lee, Carolyn Krasner, et al.. (2025). Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer. JCO Precision Oncology. 9(9). e2400882–e2400882.
4.
Manz, Christopher R., et al.. (2025). Barriers and Facilitators to Delivering Cancer Care in US Prisons. JAMA Network Open. 8(10). e2537646–e2537646. 1 indexed citations
5.
Cotner, Cody E., Angela C. Tramontano, Charlotta Lindvall, et al.. (2024). Using Oncology Treatment Pathway Data to Evaluate Serious Illness Communication, Care Utilization, and End-of-Life Care for Patients With Cancer. JCO Oncology Practice. 21(4). 535–543. 3 indexed citations
6.
Fenton, Anny, Anna Revette, Maija Reblin, et al.. (2024). “You Want to Shield Your Kids”: Patients’ and Their Adult-Children's Serious Illness Conversations. Journal of Pain and Symptom Management. 69(5). 435–443.e1. 1 indexed citations
7.
Landon, Bruce E., Miranda B. Lam, Mary Beth Landrum, et al.. (2023). Opportunities for Savings in Risk Arrangements for Oncologic Care. JAMA Health Forum. 4(9). e233124–e233124. 2 indexed citations
8.
Hammer, Marilyn J., Bruce A. Cooper, Lee-may Chen, et al.. (2023). Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster. Supportive Care in Cancer. 31(8). 485–485. 5 indexed citations
9.
Bromley-Dulfano, Rebecca, Mary Beth Landrum, Gabriel A. Brooks, Alexi A. Wright, & Nancy L. Keating. (2023). Assessing reliability of quality measures across oncology practices: Implications for value-based payment.. JCO Oncology Practice. 19(11_suppl). 4–4. 1 indexed citations
10.
Pozzar, Rachel, et al.. (2023). Developing a Collaborative Agenda-Setting Intervention (CASI) to promote patient-centered communication in ovarian cancer care: A design thinking approach. Patient Education and Counseling. 120. 108099–108099. 3 indexed citations
11.
Wright, Alexi A., et al.. (2022). The SHARE Study: Pilot Study of a Communication Intervention Designed to Elicit Advanced-Stage Cancer Patients' Preferences and Goals. Journal of Palliative Medicine. 25(11). 1646–1654. 5 indexed citations
12.
Enzinger, Andrea C., Kaushik Ghosh, Nancy L. Keating, et al.. (2021). US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life. Journal of Clinical Oncology. 39(26). 2948–2958. 61 indexed citations
13.
Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2021). Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. Journal of Clinical Oncology. 39(14). 1531–1539. 115 indexed citations
14.
Poort, Hanneke, Belle H. de Rooij, Hajime Uno, et al.. (2020). Patterns and predictors of cancer‐related fatigue in ovarian and endometrial cancers: 1‐year longitudinal study. Cancer. 126(15). 3526–3533. 29 indexed citations
15.
Poort, Hanneke, et al.. (2019). Documentation of Palliative and End-of-Life Care Process Measures Among Young Adults Who Died of Cancer: A Natural Language Processing Approach. Journal of Adolescent and Young Adult Oncology. 9(1). 100–104. 24 indexed citations
16.
Wright, Alexi A., Kari Bohlke, Deborah K. Armstrong, et al.. (2016). Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Obstetrical & Gynecological Survey. 71(12). 717–718. 19 indexed citations
17.
Esselen, Katharine M., Angel M. Cronin, Kristin Bixel, et al.. (2016). Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. Obstetrical & Gynecological Survey. 71(11). 660–661. 13 indexed citations
18.
Wright, Alexi A., Angel M. Cronin, Dana Milne, et al.. (2015). Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. Obstetrical & Gynecological Survey. 70(11). 696–697. 5 indexed citations
19.
Krishnan, Monica, Jennifer S. Temel, Alexi A. Wright, et al.. (2013). Predicting life expectancy in patients with advanced incurable cancer: a review. PubMed. 11(2). 68–74. 72 indexed citations
20.
Wright, Alexi A., Jennifer W. Mack, Patricia Kritek, et al.. (2010). Influence of patients' preferences and treatment site on cancer patients' end‐of‐life care. Cancer. 116(19). 4656–4663. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frede Olesen Breakdown of academic impact, for papers by Karen Eden Breakdown of academic impact, for papers by Sam H. Ahmedzai Breakdown of academic impact, for papers by Margaret Holmes‐Rovner Breakdown of academic impact, for papers by Hilary A. Llewellyn‐Thomas Breakdown of academic impact, for papers by Karen Basen‐Engquist Breakdown of academic impact, for papers by Thomas F. Hack Breakdown of academic impact, for papers by Margaret I. Fitch Breakdown of academic impact, for papers by Marcia Grant Breakdown of academic impact, for papers by Eva Grunfeld
Rankless by CCL
2026